| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
73,235 |
39,972 |
$3.04M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,885 |
7,831 |
$619K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,789 |
6,231 |
$254K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,021 |
2,589 |
$144K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,473 |
2,363 |
$134K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,195 |
1,419 |
$130K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
819 |
705 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
400 |
383 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,772 |
1,509 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
226 |
224 |
$12K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
608 |
473 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
598 |
502 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
98 |
96 |
$7K |
| 99382 |
|
75 |
73 |
$5K |
| 87807 |
|
531 |
466 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
58 |
55 |
$4K |
| 99381 |
|
57 |
56 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
173 |
139 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
60 |
57 |
$1K |
| 0071A |
|
16 |
14 |
$1K |
| 36410 |
|
93 |
89 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
146 |
106 |
$1K |
| 99188 |
|
172 |
138 |
$1K |
| 92523 |
|
39 |
22 |
$838.96 |
| 94010 |
|
36 |
34 |
$744.26 |
| 0001A |
|
13 |
13 |
$500.00 |
| 90688 |
|
1,219 |
1,177 |
$203.62 |
| 99050 |
|
13 |
12 |
$198.00 |
| A4217 |
Sterile water/saline, 500 ml |
142 |
109 |
$173.06 |
| 83655 |
|
25 |
25 |
$162.50 |
| 92550 |
|
13 |
12 |
$120.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
132 |
117 |
$96.64 |
| D1206 |
Topical application of fluoride varnish |
15 |
15 |
$75.00 |
| 36416 |
|
26 |
26 |
$58.90 |
| 85018 |
|
12 |
12 |
$15.67 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
28 |
17 |
$4.00 |
| 90680 |
|
1,014 |
965 |
$0.00 |
| 90698 |
|
1,348 |
1,285 |
$0.00 |
| 90744 |
|
789 |
748 |
$0.00 |
| 90716 |
|
328 |
321 |
$0.00 |
| 90686 |
|
45 |
39 |
$0.00 |
| 91307 |
|
15 |
13 |
$0.00 |
| 90633 |
|
572 |
561 |
$0.00 |
| 90670 |
|
2,056 |
1,959 |
$0.00 |
| 90707 |
|
300 |
294 |
$0.00 |
| 90685 |
|
131 |
126 |
$0.00 |
| 90700 |
|
64 |
64 |
$0.00 |
| 90648 |
|
24 |
24 |
$0.00 |
| 91300 |
|
15 |
15 |
$0.00 |
| A4218 |
Sterile saline or water, metered dose dispenser, 10 ml |
29 |
27 |
$0.00 |